נולוג'יקס 250 מ"ג

Riik: Iisrael

keel: heebrea

Allikas: Ministry of Health

Toimeaine:

BELATACEPT 25 MG/ML

Saadav alates:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

ATC kood:

L04AA28

Ravimvorm:

POWDER FOR CONCENTRATE FOR INFUSION

Manustamisviis:

I.V

Valmistatud:

BRISTOL-MYERS SQUIBB S.R.L, ITALY

Terapeutiline rühm:

BELATACEPT

Näidustused:

Nulojix, in combination with corticosteroids and mycophenolic acid (MPA), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant. It is recommended to add an interleukin (IL)-2 receptor antagonist for induction therapy to this belatacept-based regimen

Loa andmise kuupäev:

2012-08-01